Provided herein are compositions and pharmaceutical compositions comprising -terpinolene, terpinen-4-ol, and -terpineol. Also provided herein are methods of using such compositions.

Compositions and methods are provided for enhancing plant immunity, health, growth and yields. In particular, the subject invention relates to treatment and/or prevention of plant pathogenic bacterial infections using microbes and/or their growth by-products. Specifically, the subject invention can be used to treat and/or prevent citrus greening disease and citrus canker disease. In certain embodiments, the growth by-products are biosurfactants and/or enzymes.

Compositions and methods are provided for enhancing plant immunity, health, growth and yields. In particular, the subject invention relates to treatment and/or prevention of plant pathogenic bacterial infections using microbes and/or their growth by-products. Specifically, the subject invention can be used to treat and/or prevent citrus greening disease and citrus canker disease. In certain embodiments, the growth by-products are biosurfactants and/or enzymes.

The present invention is directed to pesticidal mixtures comprising sabadilla alkaloids and a pyrethroid and methods of controlling pests including insects and mites by application of pesticidal mixtures comprising sabadilla alkaloids and a pyrethroid.

The present invention is directed to pesticidal mixtures comprising sabadilla alkaloids and a pyrethroid and methods of controlling pests including insects and mites by application of pesticidal mixtures comprising sabadilla alkaloids and a pyrethroid.

Disclosed is at least one non-ionic surfactant, which is a polyol derivative, as an agent for stimulating plant growth, in particular for germination and/or root growth (including root architecture), as well as to its use as an adjuvant, the polyol derivative being a sugar derivative. The non-ionic surfactant is selected from sugar and fatty acid esters, alkylmonoglucosides, alkylpolylucosides, alkylmonoglucoside and fatty acid esters, alkylpolyglucoside and fatty acid esters, and N-alkylglucamides, in particular, sucrose esters, sorbitan esters, and glucose esters.

Disclosed is at least one non-ionic surfactant, which is a polyol derivative, as an agent for stimulating plant growth, in particular for germination and/or root growth (including root architecture), as well as to its use as an adjuvant, the polyol derivative being a sugar derivative. The non-ionic surfactant is selected from sugar and fatty acid esters, alkylmonoglucosides, alkylpolylucosides, alkylmonoglucoside and fatty acid esters, alkylpolyglucoside and fatty acid esters, and N-alkylglucamides, in particular, sucrose esters, sorbitan esters, and glucose esters.

A method of applying a Chemical Hybridization Agent (CHA) to a plant. The method includes providing a CHA source and bringing the CHA source in contact with a root of the plant. The method further includes having the root take up a part of the CHA. The disclosure further relates to methods of producing a haploid and/or doubled-haploid plant or hybrid seed. The disclosed method may be used in various aspects of plant breeding.

A method of applying a Chemical Hybridization Agent (CHA) to a plant. The method includes providing a CHA source and bringing the CHA source in contact with a root of the plant. The method further includes having the root take up a part of the CHA. The disclosure further relates to methods of producing a haploid and/or doubled-haploid plant or hybrid seed. The disclosed method may be used in various aspects of plant breeding.

A topical composition comprises at least 5 wt % metronidazole or a pharmacologically acceptable derivative thereof in a non-aqueous vehicle. The composition may be used in the treatment of conditions of the colon, rectum, anorectum and perianal region, in particular inflammatory bowel disease and perianal Crohn's disease. The composition also relieves pain and inflammation and promotes healing of the colon, rectum, anorectum and perianal region following surgical operations. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect and thus side effects observed from systemic administration are avoided.